The carbapenemase New Delhi metallo-β-lactamase-1 (NDM-1), initially identified in Escherichia coli and Klebsiella pneumoniae in 2008 in a Swedish patient who was repatriated to Sweden from India ([1][1]), is spreading rapidly worldwide except in Central and South America. Most of the reported
No takes yet. Share an insight, caveat, or question.
Nasr et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: